Company Share Buy-Backs: Valuation, Tax and HMRC Clearance

Why a buy-back is a valuation event first and a tax event second

A company purchase of own shares - a buy-back - is how most UK SME shareholders actually exit. There is no external buyer, no process, no data room. A retiring founder, a departing co-director or the estate of a deceased shareholder sells back to the company, and the company cancels the shares.

It looks administratively simple. It is not. A buy-back sits at the intersection of company law (Part 18 Companies Act 2006), tax law (sections 1033-1043 Corporation Tax Act 2010) and valuation. Get the price wrong and you have either a tax problem, a distributable-reserves problem, or an aggrieved shareholder. Frequently all three.

The two tax treatments, and why the gap is enormous

By default, the excess of the buy-back price over the original subscription price is treated as a distribution - taxed on the seller as a dividend, at up to 39.35%.

Where the conditions in section 1033 CTA 2010 are met, the buy-back instead receives capital treatment: the seller is taxed under CGT, potentially at 14% with Business Asset Disposal Relief (rising to 18% from April 2026) or otherwise at the main CGT rate.

On a £1,000,000 buy-back with a negligible base cost, the difference between the two routes is comfortably over £200,000. It is the single largest number in the transaction.

The principal conditions for capital treatment:

• The company is an unquoted trading company or the holding company of a trading group.
• The purchase is made wholly or mainly for the benefit of a trade carried on by the company - not to give the shareholder a tax advantage.
• The seller is UK resident in the tax year of purchase.
• The shares have been owned for at least five years (three years where inherited).
• The seller's interest is substantially reduced - their holding after the buy-back must be no more than 75% of the holding before, and they must not be connected with the company afterwards (broadly, under 30% including associates).

The "benefit of the trade" test is the one that turns on facts, and it is the one HMRC examines. A disagreement between shareholders that is disrupting the business, a retiring founder blocking succession, an estate that wants cash rather than shares - these are recognised trade-benefit rationales. A shareholder who simply wants money out is not.

Advance clearance under section 1044

HMRC offers a statutory advance clearance procedure under section 1044 CTA 2010. It is not mandatory. It is close to essential.

The application is a written submission to HMRC's Clearance and Counteraction Team setting out:

• The company, its trade, and its share capital before and after.
• Full details of the seller, their holding, holding period and residence.
• The commercial reason for the buy-back, framed against the trade-benefit test.
• The price and how it was arrived at.
• Funding: reserves, cash, any staged payment structure.
• Post-transaction shareholdings and confirmation the substantial reduction and connection tests are met.

HMRC normally responds within 30 days. A clearance gives certainty on treatment before completion, which is exactly when the parties need it.

The recurring reason clearances are refused or queried is not the legal analysis. It is the price. An unexplained number, or a number that appears to be a negotiated convenience rather than a valuation, invites the question of whether the real purpose was extraction rather than trade benefit.

Getting the price right

The valuation basis depends on what is being bought back.

A minority holding. The starting point is a pro-rata share of equity value, then discounts for lack of control and lack of marketability. Depending on the size of the stake and the articles, the combined discount commonly lands somewhere between 30% and 60%. Where a shareholders' agreement or the articles specify a valuation mechanism - "fair value as determined by the company's auditor", for instance - that mechanism governs, and it usually needs interpretation before it can be applied.

A controlling holding. No minority discount. A marketability discount may still apply, but a much smaller one.

An estate following death. The relevant figure often needs to reconcile with the probate valuation submitted to HMRC. Two materially different values for the same shares within a short period is an invitation to enquiry on both sides.

The tension in every SME buy-back is that the price is being agreed between parties who are not at arm's length. The seller is usually a director or a family member. The remaining shareholders benefit directly from a low price. Both HMRC and, later, any aggrieved party will look at whether an independent basis was used.

Worked illustration. Company equity value £4,000,000. Retiring shareholder holds 20%.

The remaining shareholders' proportionate interest rises because the shares are cancelled. That uplift is itself a benefit, and it is one reason the price needs to be defensible to everyone left in the company, not just to the person leaving.

Company law: the constraints that stop deals

Capital treatment is worthless if the buy-back is unlawful. Part 18 CA 2006 requires:

• Authority in the articles, or at least no prohibition. Older articles occasionally restrict buy-backs.
• Fully paid shares, and payment in full at the time of purchase. A buy-back funded by instalments is void at common law (*BDG Roof-Bond v Douglas* [2000]) unless structured through multiple completions, each a separate contract with its own approvals.
• Distributable reserves sufficient to cover the price, evidenced by relevant accounts. This is the constraint that kills more SME buy-backs than any other: a profitable company with reserves tied up in working capital and fixed assets may have the cash but not the reserves, or the reserves but not the cash.
• Shareholder approval by ordinary resolution, with the selling shareholder's votes disregarded, and the contract available for inspection.
• Form SH03 filed with Companies House within 28 days, with stamp duty at 0.5% paid on the consideration where it exceeds £1,000.

There is a small-company route allowing a purchase out of capital up to the lower of £15,000 or 5% of share capital in a financial year, and the wider (rarely used) purchase-out-of-capital procedure with a directors' solvency statement and auditor's report. Both are narrow. Most SME buy-backs are funded from distributable profits.

Multiple completion buy-backs

Where the company cannot fund the whole price at once, the standard solution is a multiple completion contract: a single contract under which the shares are bought back in tranches, with beneficial ownership passing at contract date and legal completion staged over time.

This preserves capital treatment - HMRC accepts the structure, and its own guidance recognises it - but it must be documented correctly. The seller gives up all rights (voting, dividend) at contract date, which is what satisfies the connection and substantial-reduction tests at the right moment. Each tranche needs its own reserves check at the point of completion.

It also means the seller becomes an unsecured creditor of a company they no longer control. Security, interest, and acceleration on default are all negotiable and all worth negotiating.

The five mistakes that cost most

1. Agreeing the price before anyone values the shares. The price then has to be justified after the fact, in a clearance application, to an HMRC officer who has seen this before.

2. Missing the distributable reserves test. An unlawful buy-back can be unwound, with the directors personally exposed.

3. Ignoring the five-year ownership rule. Shares transferred into a spouse's name shortly before a buy-back frequently fail it.

4. Leaving the seller connected. A retained 30%+ interest, or associates' holdings not counted, defeats capital treatment entirely.

5. Paying by instalments without a multiple completion contract. Void at common law, and capital treatment lost.

The practical sequence

1. Establish a defensible independent valuation of the shares to be purchased.

2. Confirm distributable reserves and cash availability against the valuation.

3. Structure the transaction - single or multiple completion - and confirm the substantial reduction and connection tests.

4. Apply for section 1044 clearance, with the valuation attached.

5. On clearance, execute the contract, pass the resolutions, complete, file SH03 and pay stamp duty.

6. Report the disposal on the seller's self-assessment return, with BADR claimed where available.

The order matters. The valuation is step one, not step four, because every subsequent decision - affordability, structure, clearance, tax - depends on the number. A buy-back priced properly at the outset completes in weeks. One priced by negotiation and justified afterwards is where the problems start.